Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 36,943,694
- Share change
- -1,525,261
- Total reported value
- $147,408,805
- Put/Call ratio
- 37%
- Price per share
- $3.99
- Number of holders
- 88
- Value change
- -$7,357,330
- Number of buys
- 43
- Number of sells
- 57
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
17%
|
9,903,879
|
$44,023,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
3,220,511
|
$14,315,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,961,635
|
$13,165,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.1%
|
2,479,536
|
$11,021,000 | — | 31 Mar 2022 | |
| Verition Fund Management LLC |
13F
|
Company |
3.5%
|
2,105,907
|
$9,361,000 | — | 31 Mar 2022 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
2.5%
|
1,473,459
|
$6,549,000 | — | 31 Mar 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
2.4%
|
1,447,445
|
$6,434,000 | — | 31 Mar 2022 | |
| Prosight Management, LP |
13F
|
Company |
2.3%
|
1,400,239
|
$6,224,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.3%
|
1,391,018
|
$6,183,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.6%
|
975,139
|
$4,334,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
1.6%
|
960,393
|
$4,269,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
912,868
|
$4,057,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
877,797
|
$3,902,000 | — | 31 Mar 2022 | |
| Knoll Capital Management, LLC |
13F
|
Company |
1.3%
|
759,405
|
$3,376,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.85%
|
507,700
|
$2,257,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.84%
|
504,462
|
$2,242,000 | — | 31 Mar 2022 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.84%
|
500,000
|
$2,223,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
439,453
|
$1,953,000 | — | 31 Mar 2022 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.66%
|
394,834
|
$1,755,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.63%
|
375,000
|
$1,667,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.59%
|
353,150
|
$1,570,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.57%
|
342,887
|
$1,524,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.55%
|
330,537
|
$1,470,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.49%
|
295,827
|
$1,315,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.4%
|
237,359
|
$1,137,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.4%
|
239,158
|
$1,063,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.35%
|
209,815
|
$932,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.28%
|
167,619
|
$745,000 | — | 31 Mar 2022 | |
| Palo Alto Investors LP |
13F
|
Company |
0.27%
|
160,800
|
$715,000 | — | 31 Mar 2022 | |
| DUPONT CAPITAL MANAGEMENT CORP |
13F
|
Company |
0.26%
|
158,031
|
$702,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.25%
|
150,981
|
$671,000 | — | 31 Mar 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.23%
|
137,741
|
$612,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
132,908
|
$591,000 | — | 31 Mar 2022 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.22%
|
130,000
|
$578,000 | — | 31 Mar 2022 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.21%
|
124,299
|
$553,000 | — | 31 Mar 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.19%
|
111,165
|
$494,000 | — | 31 Mar 2022 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.18%
|
108,000
|
$480,000 | — | 31 Mar 2022 | |
| Joshua Reed |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
524,825
mixed-class rows
|
$478,196 | — | 30 Mar 2022 | |
| APOGEM CAPITAL LLC |
13F
|
Company |
0.17%
|
104,042
|
$462,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.15%
|
91,293
|
$406,000 | — | 31 Mar 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.12%
|
73,068
|
$325,000 | — | 31 Mar 2022 | |
| WOODSTOCK CORP |
13F
|
Company |
0.12%
|
70,998
|
$316,000 | — | 31 Mar 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.11%
|
66,398
|
$295,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.1%
|
62,700
|
$279,000 | — | 31 Mar 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.1%
|
59,934
|
$266,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.1%
|
59,706
|
$265,000 | — | 31 Mar 2022 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
57,125
|
$254,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
53,212
|
$237,000 | — | 31 Mar 2022 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.08%
|
50,600
|
$225,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
47,596
|
$212,000 | — | 31 Mar 2022 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q2 2022
As of 30 Jun 2022,
Aldeyra Therapeutics, Inc. - Common Stock (ALDX) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,943,694 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Prosight Management, LP, Verition Fund Management LLC, EAGLE ASSET MANAGEMENT INC, Knoll Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, and 683 Capital Management, LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
102
Q2 2022 holders
88
Holder diff
-14
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.